Long-Term Outcomes after Surgery for Pheochromocytoma and Sympathetic Paraganglioma.
Francesca TorresanArianna BeberDonatella SchiavoneStefania ZovatoFrancesca GaluppiniFilippo Crimi'Filippo CeccatoMaurizio IacobonePublished in: Cancers (2023)
Lifelong follow-up is required not only for hereditary PHEO/sPGL but also for apparently benign and sporadic tumors at diagnosis because of the risk of long-term recurrent disease.